324 related articles for article (PubMed ID: 17907151)
1. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
[TBL] [Abstract][Full Text] [Related]
2. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis.
Tsuji-Yamada J; Nakazawa M; Minami M; Sasaki T
J Rheumatol; 2001 Jun; 28(6):1252-8. PubMed ID: 11409116
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
6. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
[TBL] [Abstract][Full Text] [Related]
7. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B
Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109
[TBL] [Abstract][Full Text] [Related]
8. Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
Scala E; Paganelli R; Sampogna F; Abeni D; Colonna L; De Pità O; Puddu P; Russo G
Clin Exp Immunol; 2005 Mar; 139(3):551-7. PubMed ID: 15730402
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent accumulation of monoclonal CD4+CD8+ double positive T lymphocytes in the peripheral blood of the elderly.
Ghia P; Prato G; Stella S; Scielzo C; Geuna M; Caligaris-Cappio F
Br J Haematol; 2007 Dec; 139(5):780-90. PubMed ID: 18021092
[TBL] [Abstract][Full Text] [Related]
10. Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.
Hussein MR; Hassan HI; Hofny ER; Elkholy M; Fatehy NA; Abd Elmoniem AE; Ezz El-Din AM; Afifi OA; Rashed HG
J Clin Pathol; 2005 Feb; 58(2):178-84. PubMed ID: 15677539
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin-17 production in patients with systemic sclerosis.
Kurasawa K; Hirose K; Sano H; Endo H; Shinkai H; Nawata Y; Takabayashi K; Iwamoto I
Arthritis Rheum; 2000 Nov; 43(11):2455-63. PubMed ID: 11083268
[TBL] [Abstract][Full Text] [Related]
12. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
[TBL] [Abstract][Full Text] [Related]
13. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
Steen VD; Engel EE; Charley MR; Medsger TA
J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
[TBL] [Abstract][Full Text] [Related]
14. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
[TBL] [Abstract][Full Text] [Related]
15. In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis.
Gruschwitz MS; Albrecht M; Vieth G; Haustein UF
J Rheumatol; 1997 Oct; 24(10):1936-43. PubMed ID: 9330935
[TBL] [Abstract][Full Text] [Related]
16. High levels of intracellular IL-4 are expressed in circulating apoptotic T cells in patients with tuberculosis and in community controls.
Veenstra H; Baumann R; Lukey PT; Beyers N; van Helden PD; Walzl G
Tuberculosis (Edinb); 2008 Jan; 88(1):21-30. PubMed ID: 17977794
[TBL] [Abstract][Full Text] [Related]
17. Increased transendothelial migration of scleroderma lymphocytes.
Stummvoll GH; Aringer M; Grisar J; Steiner CW; Smolen JS; Knobler R; Graninger WB
Ann Rheum Dis; 2004 May; 63(5):569-74. PubMed ID: 15082489
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
[TBL] [Abstract][Full Text] [Related]
19. T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro.
Del Galdo F; Jiménez SA
Arthritis Rheum; 2007 Oct; 56(10):3478-88. PubMed ID: 17907195
[TBL] [Abstract][Full Text] [Related]
20. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.
Giacomelli R; Matucci-Cerinic M; Cipriani P; Ghersetich I; Lattanzio R; Pavan A; Pignone A; Cagnoni ML; Lotti T; Tonietti G
Arthritis Rheum; 1998 Feb; 41(2):327-34. PubMed ID: 9485091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
